Catherine Green
University of Oxford
H-index: 50
Europe-United Kingdom
Top articles of Catherine Green
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with … | Open Forum Infectious Diseases | Alison Uriel Pedro Garbes A Nagare JC Kuan Christine Palmer | 2023/12 |
Loss of FAM111B protease mutated in hereditary fibrosing poikiloderma negatively regulates telomere length | Frontiers in Cell and Developmental Biology | Maciej Kliszczak Daniela Moralli Julia D Jankowska Paulina Bryjka Lamia Subha Meem | 2023/6/5 |
Transcriptomic response and immunological responses to chimpanzee adenovirus-and MVA viral-vectored vaccines for RSV in healthy adults | Clinical and experimental immunology | Catherine Green Joseph McGinley C Sande Stefania Capone S Makvandi-Nejad | 2023/3/1 |
Cognitive therapy for PTSD following birth trauma and baby loss: clinical considerations | the Cognitive Behaviour Therapist | Alice Kerr Emma Warnock-Parkes Hannah Murray Jennifer Wild Nick Grey | 2023/1 |
In vitro characterisation of spontaneously immortalised Non-Human Primate Müller glia cell lines as a potential source for cell replacement therapies for retinal degenerative … | Investigative Ophthalmology & Visual Science | Ahmed Salman Aranxta Bolinches Amoros Alun Barnard Daniela Moralli Paulina Brijka | 2022/6/1 |
APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types | BMC biology | G Maria Jakobsdottir Daniel S Brewer Colin Cooper Catherine Green David C Wedge | 2022/12 |
RNA-seq analysis of the human surfactant air-liquid interface culture reveals alveolar type II cell-like transcriptome | Molecular Therapy-Methods & Clinical Development | Altar M Munis Benjamin Wright Frederic Jackson Helen Lockstone Stephen C Hyde | 2022/3/10 |
Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs | Biotechnology and bioengineering | Carina CD Joe Jinlin Jiang Thomas Linke Yuanyuan Li Sofiya Fedosyuk | 2022/1 |
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial | The Lancet Microbe | Daniel Jenkin Adam J Ritchie Jeremy Aboagye Sofiya Fedosyuk Luke Thorley | 2022/9/1 |
Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma | Nature Communications | Stefan Antonowicz Zsolt Bodai Tom Wiggins Sheraz R Markar Piers R Boshier | 2021/3/5 |
Vaxxers: a pioneering moment in scientific history | Sarah Gilbert Catherine Green | 2021/7/8 | |
When the genome bluffs: a tandem duplication event during generation of a novel Agmo knockout mouse model fools routine genotyping | Cell & Bioscience | Sabrina Sailer Stefan Coassin Katharina Lackner Caroline Fischer Eileen McNeill | 2021/12 |
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature medicine | Katie J Ewer Jordan R Barrett Sandra Belij-Rammerstorfer Hannah Sharpe Rebecca Makinson | 2021/2 |
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (vol 27, pg 279, 2021) | Nature medicine | Jordan R Barrett Sandra Belij-Rammerstorfer Christina Dold Katie J Ewer Pedro M Folegatti | 2021/2 |
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) | The Lancet | Amy Flaxman Natalie G Marchevsky Daniel Jenkin Jeremy Aboagye Parvinder K Aley | 2021/9/11 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK | The Lancet | Merryn Voysey Sue Ann Costa Clemens Shabir A Madhi Lily Y Weckx Pedro M Folegatti | 2020/12/8 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial | The Lancet | Katherine RW Emary Tanya Golubchik Parvinder K Aley Cristina V Ariani Brian Angus | 2021/4/10 |
Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions | Nature Communications | Siwy Ling Yang Louis DeFalco Danielle E Anderson Yu Zhang Jong Ghut Ashley Aw | 2021/8/25 |
Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules (preprint) | Yue Wan Siwy Ling Yang Louis DeFalco Danielle E Anderson Yu Zhang | 2021 | |
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine | ACS central science | Yasunori Watanabe Luiza Mendonça Elizabeth R Allen Andrew Howe Mercede Lee | 2021/4/2 |
